UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 81

of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'

81
TI
Bevacizumab-induced cardiovascular events: a consequence of cholesterol emboli syndrome?
AU
Mir O, Mouthon L, Alexandre J, Mallion JM, Deray G, Guillevin L, Goldwasser F
SO
J Natl Cancer Inst. 2007;99(1):85.
 
AD
PMID